Key facts
- This page summarizes PAVmed Inc.'s Form 4 filing for Lucid Diagnostics Inc. (LUCD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 Feb 2024, 16:49.
PAVmed Inc. - 15 Feb 2024 Form 4 Insider Report for Lucid Diagnostics Inc. (LUCD)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- LUCD
- Reported as of
- 15 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Feb 2024, 16:49:05 UTC
- Prior SEC filing
- 30 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dennis M. McGrath, as Chief Financial Officer of the Reporting Person
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
PAVmed Inc. filed Form 4 for Lucid Diagnostics Inc. (LUCD) on 20 Feb 2024.
Change
- Previous filing in this sequence was filed on 30 Jan 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LUCD
transaction
Common Stock
Other
- Transaction value
- Shares
- -3,331,747
- Change %
- -9.6%
- Price
- Shares after
- 31,302,444
- Date
- 15 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Distribution by the Reporting Person as a pro rata dividend to the owners of common and preferred stock of the Reporting Person.